Intrinsiqq
Electromed Inc. logo

Electromed Inc. Quality Score

ELMD

⊜ Compare
Quality75

Business quality remains strong (avg 95/100), but growth is pulling the composite down (avg 50/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
80/100
21.5x

20–25x range, moderate premium

Cash Flow Multiple
60/100
27.9x

25–30x, paying up for cash generation

Revenue Growth
100/100
15.4%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
-2.1%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
80/100
-0.1%

Roughly flat, no meaningful dilution

Margin Trend
100/100
+10.5pp

Expanded 3+pp, strong improvement

Capital Structure
100/100
-$20M

Net cash position, no leverage concern

2023
$7.00M
$161000
2024
$16.0M
$87000
2025
$15.0M
$198000
2026
$20.0M
$133000
CashDebt
Return on Capital
100/100
22.2%

Above 20%, exceptional capital efficiency

Customize WeightsPremiumUpgrade

Electromed (ELMD) quality: score, margins and returns

Electromed (ELMD) scores 75/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 18.8% operating margins and 22.2% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Electromed (ELMD) a high-quality business?+

Electromed scores 75 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 18.8% operating margin and a 22.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Electromed's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from ELMD's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Electromed scores well and where it falls behind.

What is Electromed's return on invested capital (ROIC)?+

Electromed earns about 22.2% on its invested capital, which is exceptional. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to ELMD's margins and growth on this scorecard to judge durability.

How profitable is Electromed?+

Electromed runs an operating margin of about 18.8% and a net margin of about 15.3%. Revenue has grown at roughly 15.6% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 19 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends Jun. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with ELMD

CompareIntrinsic value
EDAPEdap Tms SA
$4.34+5.60%15
VASOVaso Corporation
$0.29+0.00%37
IRIXIridex Corporation
$0.72+2.86%25
CBLLCeribell, Inc.
$27.39-3.11%25
FONRFonar Corp
No recent price53
BLFSBiolife Solutions Inc.
No recent price61
ZYXIQZynex Inc
No recent price20
ECORElectroCore, Inc.
$8.40+16.18%40

Held by ETFs

ELMD is in 12 US ETFs. The largest of them, with ELMD's weight in each:

Spot a number that looks wrong? Check it in ELMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ELMD

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.